Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

What routine mammograms can tell us about a woman’s CVD risk

Signs of breast arterial calcification on a patient’s routine mammogram may suggest they face a greater risk of cardiovascular disease.

ACC consensus explains what cardiologists should look for in long COVID-19

The new consensus document provides a framework for understanding, evaluating, and managing some of the key cardiovascular sequelae of COVID-19

ECMO unit in service at Banner Medical Center in Phoenix.

‘We learned that lung recovery was actually possible’: ECMO’s impact on COVID-19 patients in the ICU

The study's authors emphasized the importance of careful patient selection. 

coronavirus COVID-19 vaccine vaccination

Pfizer CEO says fourth COVID-19 shot is necessary

A second booster shot may be necessary to protect against COVID-19.

 

Thumbnail

Intrathoracic complications in COVID patients: Incidence, associations and outcomes

New research published in Clinical Imaging links specific adverse findings on chest imaging of COVID patients to ICU admission, need for intubation and length of hospital stay. 

Thumbnail

Less work, more stress—how interventional radiology departments felt the impact of COVID

Survey results published in CardioVascular and Interventional Radiology reveal how interventional departments fared during the first two waves of the pandemic, as well as how organizations are preparing for future outbreaks.

Telehealth provided value for heart failure patients during COVID-19 pandemic

Overall, researchers found, 30-day readmission was less common when heart failure patients used telehealth to check in with a physician after discharge. 

Thumbnail

Pfizer finalizes $6.7 billion acquisition of Arena Pharmaceuticals, gaining key cardiovascular treatments

Etrasimod, an oral medication developed to treat certain inflammatory conditions, was at the center of Pfizer’s acquisition, but some key cardiovascular assets were also part of the transaction.